Scheme

Mirae Asset Healthcare Fund

Holds 29 companies worth ₹3,493 Cr in Sept 2026.

Fund house
MiraeThe fund house that runs this scheme.
AUM
₹3,494 CrMirae Asset Healthcare Fund's AUM at the end of 30 Sept 2026, as AMFI reports it. Down 1.7% on Aug 2026, ₹3,555 Cr.
Largest holding
Sun Pharmaceutical Ind LtdSun Pharmaceutical Ind Ltd is 10.1% of this scheme's NAV.
Fund manager
Vrijesh KaseraRuns it since 2 Jul 2018, as the fund house dates it. With Tanmay Mehta (fund manager).

Holdings^{(Jul 2018 – Sept 2026)}

Holdings in Sept 2026. Tick up to 2 to plot them.
Plot	29 companies ·	₹ Cr
	Sun Pharmaceutical Ind Ltd	355
	Divi s Laboratories Limited	342
	Torrent Pharmaceuticals Limited	238
	Apollo Hospitals Enterprise Limited	196
	Laurus Labs Limited	193
	Dr Reddy s Laboratories Limited	169
	Glenmark Pharmaceuticals	167
	Aurobindo Pharma	132
	Alkem Laboratories Limited	131
	IPCA Laboratories Limited	118
	Krishna Institute of Medical Science Ltd	118
	Aster DM Healthcare Limited	116
	Sai Life Sciences Limited	113
	Onesource Speciality Pharma Ltd	105
	Fortis Healthcare Limited	103
	Dr Lal Path Labs Limited	101
	Gland Pharma Limited	93.9
	Cipla	92
	Eris Lifesciences Limited	83.4
	Max Healthcare Institute Limited	82
	Lupin	79.2
	Mankind Pharma Limited	78.4
	Biocon	70.1
	Molbio Diagnostics Limited	61.9
	Symbiotec Pharmalab Limited	55.8
	Neogen Chemicals Limited	52.5
	Anthem Biosciences Limited	32.5
	Deepak Nitrite Limited	14
	Narayana Hrudayalaya Limited	0.04

Sun Pharmaceutical Ind Ltd
Divi s Laboratories Limited

Market value of each ticked company in Mirae Asset Healthcare Fund, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
Month	Sun Pharmaceutical Ind Ltd	Divi s Laboratories Limited
Sept 2025	₹320 Cr	₹214 Cr
Oct 2025	₹339 Cr	₹250 Cr
Nov 2025	₹367 Cr	₹241 Cr
Dec 2025	₹345 Cr	₹238 Cr
Jan 2026	₹320 Cr	₹225 Cr
Feb 2026	₹335 Cr	₹232 Cr
Mar 2026	₹336 Cr	₹218 Cr
Apr 2026	₹346 Cr	₹242 Cr
May 2026	₹344 Cr	₹248 Cr
Jun 2026	₹356 Cr	₹245 Cr
Jul 2026	₹381 Cr	₹300 Cr
Aug 2026	₹387 Cr	₹352 Cr
Sept 2026	₹355 Cr	₹342 Cr

Fig. 1.Market value of each ticked company in Mirae Asset Healthcare Fund, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Allocation^{(Sept 2026)}

Market cap

		% of NAV
Large Cap	5	34.99

Mid Cap	14	42.11

Small Cap	8	19.51

Unlisted	2	3.37

Sectors

Companies

Fig. 2.This scheme's holdings, by market cap, by sector and by company. Hover a slice or a row; click a slice to open it.

Buying and selling, month by month^{(Oct 2025 – Sept 2026)}

Buying and selling, month by month. Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Fig. 3.Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Portfolio^{(Sept 2026)}

Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures. Click a column's header to sort by it.

Sun Pharmaceutical Ind Ltd	Equity	Pharmaceuticals & Biotechnology	19.5L	355	10.15
Divi s Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	3.68L	342	9.79
Torrent Pharmaceuticals Limited	Equity	Pharmaceuticals & Biotechnology	4.95L	238	6.80
Apollo Hospitals Enterprise Limited	Equity	Healthcare Services	2.4L	196	5.62
Laurus Labs Limited	Equity	Pharmaceuticals & Biotechnology	9.73L	193	5.51
Dr Reddy s Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	13.7L	169	4.84
Glenmark Pharmaceuticals	Equity	Pharmaceuticals & Biotechnology	7.15L	167	4.78
Aurobindo Pharma	Equity	Pharmaceuticals & Biotechnology	7.89L	132	3.78
Alkem Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	2.54L	131	3.76
IPCA Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	6.15L	118	3.39
Krishna Institute of Medical Science Ltd	Equity	Healthcare Services	15.9L	118	3.39
Aster DM Healthcare Limited	Equity	Healthcare Services	16.7L	116	3.33
Sai Life Sciences Limited	Equity	Pharmaceuticals & Biotechnology	7.4L	113	3.23
Onesource Speciality Pharma Ltd	Equity	Pharmaceuticals & Biotechnology	6.92L	105	3.01
Fortis Healthcare Limited	Equity	Healthcare Services	13.3L	103	2.94
Dr Lal Path Labs Limited	Equity	Healthcare Services	5.1L	101	2.90
Gland Pharma Limited	Equity	Pharmaceuticals & Biotechnology	3.24L	93.9	2.69
Cipla	Equity	Pharmaceuticals & Biotechnology	6.84L	92	2.63
Eris Lifesciences Limited	Equity	Pharmaceuticals & Biotechnology	7L	83.4	2.39
Max Healthcare Institute Limited	Equity	Healthcare Services	8.81L	82	2.35
Lupin	Equity	Pharmaceuticals & Biotechnology	3.9L	79.2	2.27
Mankind Pharma Limited	Equity	Pharmaceuticals & Biotechnology	3.13L	78.4	2.24
Biocon	Equity	Pharmaceuticals & Biotechnology	18.9L	70.1	2.00
Molbio Diagnostics Limited	Equity	Healthcare Equipment & Supplies	4.73L	61.9	1.77
Symbiotec Pharmalab Limited	Equity	Pharmaceuticals & Biotechnology	4.74L	55.8	1.60
Neogen Chemicals Limited	Equity	Chemicals & Petrochemicals	2.14L	52.5	1.50
Anthem Biosciences Limited	Equity	Pharmaceuticals & Biotechnology	3.78L	32.5	0.93
Deepak Nitrite Limited	Equity	Chemicals & Petrochemicals	91.5K	14	0.40
Narayana Hrudayalaya Limited	Equity	Healthcare Services	199	0.04	0.001

Fig. 4.Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures.